Navigation Links
Questcor Teams With Child Neurology Foundation (CNF) to Fund Infantile Spasms Scientific Research

UNION CITY, Calif., Oct. 14 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced that it is partnering with the Child Neurology Foundation (CNF) to fund a $30,000 grant to support research into infantile spasms (IS). Catherine Chu-Shore, MD, of Massachusetts General Hospital was selected by CNF as the recipient of this first-ever "Logan Infantile Spasms Research Award."

"Questcor is committed to CNF and the entire infantile spasms community," said Steve Cartt, Executive Vice President and Chief Business Officer for Questcor. "Further research into this devastating condition is imperative and we feel strongly about supporting initiatives that will advance the knowledge and treatment of infantile spasms."

Dr. Chu-Shore, whose application was reviewed by 10 of the nation's top child neurologists and then selected by the CNF Board of Directors, said she will focus her research on the "functional network connectivity" in infantile spasms. IS is a severe, ultra-rare form of childhood epilepsy that can lead to long-term cognitive impairment if it is not quickly and successfully treated. The goal of her research is to identify early metrics of altered brain connectivity which can serve as biomarkers for prognostication and treatment stratification for infants with IS.

"I am very grateful to be the recipient of the Child Neurology Foundation's Logan Infantile Spasms Research Award," said Dr. Chu-Shore. "This grant provides me with the opportunity to develop my career as a physician scientist and better understand the mechanisms of pediatric neurologic disease and their impact on functional neurodevelopment."

Dr. Chu-Shore completed her child neurology training at Massachusetts General Hospital (MGH). Following a year where she was involved in post-doctoral research, she then completed a combination epilepsy and neurophysiology fellowship at MGH. In 2010, Dr. Chu-Shore joined the staff at MGH in the Pediatric Neurology and Neurophysiology Programs.

Dr. Chu-Shore will be honored and presented with the award at a special luncheon today at the CNS Annual Meeting in Providence, Rhode Island.

"Research into orphan disorders like infantile spasms often suffers from a lack of funding," said Lawrence W. Brown, MD, Associate Professor of Neurology and Pediatrics at the Children's Hospital of Philadelphia and President of the Child Neurology Foundation. "That is why we are pleased to partner with Questcor Pharmaceuticals. They have made a multi-year commitment to fund basic research into the causes and consequences of infantile spasms. Our hope is that better understanding of the underlying pathophysiology will lead to new and even more effective treatments for this very rare but devastating form of childhood epilepsy."

Infantile Spasms

Infantile Spasms is a severe, ultra-rare form of epilepsy that affects infants, with onset typically occurring during the first year of life in about 90 percent of cases. IS incidence is estimated at approximately 2,000 new cases in the U.S. per year, which can be classified as an ultra-orphan disease. For comparison, orphan disease designation pertains to diseases that affect fewer than 200,000 people. IS patients experience rapid, characteristic muscular contraction or extensions lasting one to two seconds and occurring in clusters ranging from a few spasms to more than 100 spasms per cluster. Often, in the beginning, the attacks are brief, infrequent and not typical, so it is quite common for the diagnosis to be delayed. Frequently, due to the pattern of the attacks and the cry that an infant gives during or after an attack, the attacks are sometimes initially thought to be due to colic or gastric distress.  

About the Child Neurology Foundation

Founded in October 2000, the Child Neurology Foundation was created as the outreach and philanthropic arm of the Child Neurology Society. Members of the CNS include more than 1,300 child neurologists from the United States, Canada, as well as more than 30 other countries around the world.

The Foundation's mission is to advocate for children and adolescents with neurologic and developmental disorders; fund neurologic research of young investigators; promote awareness of career opportunities in child neurology; provide public, professional, and patient education programs; and support the activities and mission of the CNS.

For more information on the CNF, please visit

About Questcor Pharmaceuticals

Questcor is a biopharmaceutical company whose products help patients with serious, difficult-to-treat medical conditions. Questcor's specific areas of focus are in the fields of neurology and nephrology and the company is currently supporting research efforts in a variety of conditions having significant unmet medical need.  For more information, please visit

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Questcor and Child Neurology Foundation Support the 2nd Annual Infantile Spasms (IS) Awareness Week
2. Questcor to Present at UBS Global Life Sciences Conference
3. Mitchell J. Blutt, M.D. Appointed to Questcor Board of Directors
4. Questcor Receives Notification of PDUFA Date Extension to September 11, 2010
5. Questcor to Present at the Jefferies 2010 Global Life Sciences Conference
6. Trading Halted Today in Questcor Pharmaceuticals Common Stock
7. Questcor to Discuss Results From FDA Panel Meeting
8. Questcor Reports Solid Fourth Quarter Results
9. Airline Passenger Experience Association Teams Up With ORBIS International in Their Fight Against Avoidable Blindness
10. Profil Institute Teams Up With American Diabetes Association to Step Out Against Diabetes
11. Anthem Healthcare Intelligence Teams with Oracle to Offer Healthcare Analytic Applications
Post Your Comments:
(Date:11/30/2015)... November 30, 2015 ... adds a 2015 publication ... - 2015 with comprehensive analysis of ... of deal types, such as Mergers ... . ...
(Date:11/30/2015)... 2015 --> --> ... Market by Product (Soft Tissue, All Tissue, Dental Welding Lasers), ... and Geography - Global Forecast to 2020", published by MarketsandMarkets, ... a CAGR of 5.2% during the forecast period from 2015 ... and 62 Figures spread through 167 P ages and ...
(Date:11/30/2015)... SAN DIEGO , Nov. 30, 2015 /PRNewswire/ ... ARNA ) today announced that the U.S. Food and ... Drug Application (NDA) for an extended release formulation of ... patients a chronic weight management treatment in a once-daily ... approved as an adjunct to a reduced-calorie diet and ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... SonaCare ... 2015 HSJ Acute Sector Innovation Award on November 18th. This prestigious award recognizes ... and propose exciting enhancements to the medical landscape. , The UCLH team won ...
(Date:11/30/2015)... , ... December 01, 2015 , ... The Turks & ... one of the leading digital news sites highlighting Caribbean destinations, has published five reasons ... While much of North America shivers under chilly grey skies or worse, it's typically ...
(Date:11/30/2015)... ... December 01, 2015 , ... Live Very Well is ... insurance plans on . The multi-carrier insurance exchange platform offers individual ... allowing consumers to compare, quote and match plans to meet their needs. ...
(Date:11/30/2015)... ... ... According to research by the National Association of Dental ... certified or obtain continuing education. To increase awareness of the lack of standards ... inform dentists that the technicians they trust could lack the skills and knowledge ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... The world ... strip harvesting and follicular unit extraction. These techniques and procedures have been in use ... suffering from hair loss. While Dr. Parsa Mohebi, M.D. has utilized many of these ...
Breaking Medicine News(10 mins):